Cyril Amarchand Mangaldas advised the placement agents, IIFL Capital Services Limited and Jefferies India Private Limited on the qualified institutions placement of equity shares of Krishna Institute of Medical Sciences aggregating to INR 1,500 crore (“QIP”). The QIP opened on June 16, 2026, and closed on June 19, 2026.
The Company provides multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare, and operates 26 multi-specialty and super specialty hospitals under the “KIMS Hospitals” brand across Telangana, Andhra Pradesh, Maharashtra, Karnataka and Kerala.
The proceeds of the QIP are proposed to be utilized towards re-payment and /or prepayment of certain outstanding borrowings of the Company and certain of its subsidiaries, and general corporate purposes.
The deal team was led by Reuben Chacko, Partner (Regional Co-Head – Capital Markets – South) and Abhyuday Bhotika, Partner; with support from Aniran Ghoshal, Sravya Surapaneni, Principal Associates; Bhaskar Kumar, Senior Associate Designate; Namita Kaushik, Eashaan Agrawal and Mitali Mangalam, Associates.
